Funding Opportunity RFA-CA-21-036 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) solicits Small Business Innovation Research (SBIR) applications from small business concerns (SBCs) that seek additional funding to support the next stage of development for cancer-relevant projects that were previously funded under SBIR or STTR Phase II awards from any Federal agency. The purpose of this FOA is to facilitate the transition of SBIR or STTR Phase II projects to the commercialization stage. This FOA is expected to promote partnerships between Federally-funded SBIR or STTR Phase II awardees and third-party investors and/or strategic partners to facilitate and accelerate the capital-intensive steps that are required to commercialize new products and services. Applicants must submit a Commercialization Plan, which should include details on any independent third-party investor funding that has already been secured or is anticipated during the Phase IIB Bridge Award project period. It is expected that the level of this independent third-party funding will be equal to or greater than the NCI funds being requested throughout the Phase IIB Bridge Award project period. Proposed projects may address preclinical and/or clinical stages of technology development. Clinical trials may be proposed as appropriate but are not required.

Notice NOT-HD-21-023 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-022 from the NIH Guide for Grants and Contracts

Notice NOT-HD-21-021 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-21-166 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.

Funding Opportunity PAR-21-206 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate scientific discoveries and engineering developments into methods or tools that address problems in basic research to understand disease, or in applied research to assess risk, detect, prevent, diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet evolving requirements for technologies and methods relevant to the advance of research and delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions and diseases within the missions of participating institutes.

Competitive Salary: EMBL: About this position We are looking for a Senior Graphic Designer to join the Communications team at EMBL’s European Bioinformatics Institute (EMBI- Hinxton, Cambridgeshire, England

Funding Opportunity PAR-21-143 from the NIH Guide for Grants and Contracts. The purpose of the NHGRI Predoctoral to Postdoctoral Transition Award for a Diverse Genomics Workforce (F99/K00) is to support a defined pathway across career stages for talented graduate students from diverse backgrounds, including those from groups underrepresented in biomedical, clinical, behavioral and social sciences. This two-phased award will facilitate completion of a doctoral dissertation (F99) and transition to a strong postdoctoral research position (K00) focused on the scientific, medical, ethical, social and/or legal areas of genomics research. It is anticipated that successful completion of this phased award program will have provided students sufficient scientific and career development activities to set them on the path to becoming independent genomics researchers. This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Notice NOT-DA-21-028 from the NIH Guide for Grants and Contracts

This researcher shares four strategies she employed

Develop and adopt new bioinformatic capabilities for prokaryotic and eukaryotic datasets. Expertise in bioinformatic programming languages, with preference in R…
From INTERNATIONAL FLAVORS & FRAGRANCES - Thu, 25 Mar 2021 02:05:34 GMT - View all Madison, WI jobs

Notice NOT-AA-21-008 from the NIH Guide for Grants and Contracts

Notice NOT-DA-21-033 from the NIH Guide for Grants and Contracts

Negotiable: Paramount Recruitment: Bioinformatics Scientist Algorithm and Assay Development Cambridge This is a great opportunity for a strong Bioinformatics Scientist to join t Cambridge, England

Notice NOT-OD-21-080 from the NIH Guide for Grants and Contracts

Competitive Salary: EMBL: About this position The Database Team provides day-to-day Database Administration and Engineering for the production, development, and test databas Hinxton, Cambridgeshire, England

“Remember that you are talking to a human with real emotions,” our Letters to Young Scientists columnists write

Notice NOT-TW-21-004 from the NIH Guide for Grants and Contracts

Notice NOT-TW-21-003 from the NIH Guide for Grants and Contracts

Notice NOT-NS-21-041 from the NIH Guide for Grants and Contracts